Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide versus fluticasone for AMP bronchial responsiveness in adults with asthma
NL-OMON29179Recruiting
- Sponsor
- Altana Pharma
- Start
- Apr 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in asthma comparing Ciclesonide arm with Fluticasone arm (2 arms). Primary endpoint: Effect of particle size of aerosolized AMP on bronchial responsiveness in asthma. Started Apr 2006; status: recruiting.
02
Drugs
ciclesonidefluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NL-OMON29179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29179.